Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: ZYMERON CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-02-07 to 2026-06-06
Current total value of award: $2999992.85
Description: DEFENSE HEALTH AGENCY SMALL BUSINESS INNOVATION RESEARCH PHASE II MEDICAL R&D CONTRACT FOR DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME